This is a Validated Antibody Database (VAD) review about mouse Dnajc5, based on 6 published articles (read how Labome selects the articles), using Dnajc5 antibody in all methods. It is aimed to help Labome visitors find the most suited Dnajc5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Dnajc5 synonym: 2610314I24Rik; AU018536; Csp; dnaJ homolog subfamily C member 5; DnaJ (Hsp40) homolog, subfamily C, member 5; cysteine string protein

Santa Cruz Biotechnology
mouse monoclonal (16)
  • ELISA; human
In order to investigate how glimepiride protects neurons against synapse damage induced by Abeta, Santa Cruz Biotechnology Dnajc5 antibody (Santa Cruz, sc-136468) was used in ELISA on human samples . Neuropharmacology (2016) ncbi
mouse monoclonal (16)
  • ELISA; human
Santa Cruz Biotechnology Dnajc5 antibody (Santa Cruz, sc-136468) was used in ELISA on human samples . Neuropharmacology (2016) ncbi
mouse monoclonal (16)
  • ELISA; mouse; fig 1b
Santa Cruz Biotechnology Dnajc5 antibody (Santa Cruz, sc-136468) was used in ELISA on mouse samples (fig 1b). Biomolecules (2015) ncbi
Synaptic Systems
rabbit polyclonal (/)
  • western blot; human; 1:1000; loading ...; fig 6f
Synaptic Systems Dnajc5 antibody (Synaptic Systems, 154 003) was used in western blot on human samples at 1:1000 (fig 6f). Mol Syst Biol (2018) ncbi
Enzo Life Sciences
rabbit polyclonal
  • western blot; human; 1:5000; fig 6A
Enzo Life Sciences Dnajc5 antibody (Enzo life science, ADI-VAP-SV003-E) was used in western blot on human samples at 1:5000 (fig 6A). Acta Neuropathol Commun (2015) ncbi
Invitrogen
rabbit polyclonal
  • western blot; human; 1:200; fig s1b
Invitrogen Dnajc5 antibody (Thermo-Scientific-Pierce, PA5-49570) was used in western blot on human samples at 1:200 (fig s1b). PLoS ONE (2017) ncbi
Articles Reviewed
  1. Trepte P, Kruse S, Kostova S, Hoffmann S, Buntru A, Tempelmeier A, et al. LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells. Mol Syst Biol. 2018;14:e8071 pubmed publisher
  2. Braga A, Carneiro B, Batista M, Akinaga M, Bittar C, Rahal P. Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity. PLoS ONE. 2017;12:e0188467 pubmed publisher
  3. Benítez B, Cairns N, Schmidt R, Morris J, Norton J, Cruchaga C, et al. Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss. Acta Neuropathol Commun. 2015;3:73 pubmed publisher
  4. Osborne C, West E, Nolan W, McHale Owen H, Williams A, Bate C. Glimepiride protects neurons against amyloid-β-induced synapse damage. Neuropharmacology. 2016;101:225-36 pubmed publisher
  5. Williams R, Bate C. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling. Neuropharmacology. 2016;101:566-75 pubmed publisher
  6. Bate C, Williams A. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2. Biomolecules. 2015;5:178-93 pubmed publisher